Why MOLN? Molecular Partners AG Analysis, Price & AI Insights | Whystock
MOLN
$4.24+0.01 (+0.24%)
Market ClosedLast close May 1
Molecular Partners AG, a clinical-stage biotechnology company, designs and develops designed ankyrin repeat proteins therapeutics for the treatment of oncology diseases in Switzerland.